Dual Chamber Versus Single Chamber Cardiac Pacing in People 80 Years of Age and Older

NCT00116987 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 800

Last updated 2015-06-15

No results posted yet for this study

Summary

Of the 19,000 pacemakers implanted across Canada in 2002, 1/3 of them were for patients 80 years and older. This is the fastest growing segment of our population, yet no study has specifically been done in this age group to determine the optimal pacing mode.

We wish to determine whether dual chamber or single chamber pacing is associated with a reduction in emergency room visits or hospitalizations for cardiovascular causes (e.g., congestive heart failure (CHF), atrial fibrillation (AF)) resulting in improved quality of life.

Conditions

Interventions

DEVICE

Dual chamber cardiac pacemaker

Physiologic pacemakers usually have two leads - one positioned in the right atrium (upper heart chamber) and one positioned in the right ventricle.

DEVICE

Single chamber cardiac pacemaker

Ventricular pacemakers have a single lead (wire) positioned in the right ventricle (lower pumping chamber) to sense and pace the ventricle.

Sponsors & Collaborators

  • Calgary Health Trust

    collaborator OTHER
  • University of Calgary

    lead OTHER

Principal Investigators

  • Anne M Gillis, MD · Director of Pacing and Electrophysiology, Professor of Medicine, University of Calgary

  • Derek V Exner, MD, MPH · University of Calgary

  • D. George Wyse, MD, PhD · University of Calgary

  • L. Brent Mitchell, MD · University of Calgary

  • Robert S Sheldon, MD, Ph D · University of Calgary

  • John M Rothschild, MD · University of Calgary

  • Henry J Duff, MD · University of Calgary

  • John Burgess, MD · University of Calgary

  • Alexander Bayes, MD · University of Calgary

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-08-31
Primary Completion
2008-09-30
Completion
2009-11-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00116987 on ClinicalTrials.gov